SUPRIYA

Supriya Lifescience Share Price Supriya Lifescience

₹358.1
6.05 (1.72%)
27 February, 2024 22:40 BSE: 543434 NSE: SUPRIYAISIN: INE07RO01027

Start SIP in Supriya Lifescience

Start SIP

Supriya Lifescience Performance

Day Range

  • Low 352
  • High 365
₹ 358

52 Week Range

  • Low 170
  • High 394
₹ 358
  • Open Price352
  • Previous Close352
  • Volume323726

Supriya Lifescience Share Price

  • Over 1 Month 15.85%
  • Over 3 Month 29.61%
  • Over 6 Month 32.83%
  • Over 1 Year 80.72%

Supriya Lifescience Key Statistics

P/E Ratio 23.9
PEG Ratio 1
Market Cap Cr 2,882
Price to Book Ratio 4.1
EPS 11.2
Dividend 0.2
Relative Strength Index 60.93
Money Flow Index 69.81
MACD Signal 13.46
Average True Range 18.25
Supriya Lifescience Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 140140132142
Operating Expenses Qtr Cr 991088887
Operating Profit Qtr Cr 41324455
Depreciation Qtr Cr 4443
Interest Qtr Cr 0011
Tax Qtr Cr 1061415
Net Profit Qtr Cr 30242938
IndicatorMar 2023
Total Revenue Annual Cr 470
Operating Expenses Annual Cr 332
Operating Profit Annual in Cr 129
Depreciation Cr 12
Interest Annual Cr 3
Tax Annual Cr 34
Net Profit Annual Cr 90
IndicatorMar 2023
Cash from Operating Activity Annual Cr 66
Cash from Investing Activity Annual Cr -133
Cash from Financing Annual Activity Cr -3
Net Cash Flow Annual Cr -70
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 699
Fixed Assets Annual Cr 329
Total Non Current Assets Annual Cr 355
Total Current Assets Annual Cr 465
Total Assets Annual Cr 820
IndicatorMar 2023
Book Value Per Share Annual Rs 87
ROE Annual % 13
ROCE Annual % 17
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 30
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual -
EBDIT Annual Margin %

Supriya Lifescience Technicals

EMA & SMA

Current Price
₹358.1
6.05 (1.72%)
pointer
  • Bullish Moving Average
  • ___
  • 15
  • Bearish Moving Average
  • ___
  • 1
  • 20 Day
  • ₹342.51
  • 50 Day
  • ₹320.95
  • 100 Day
  • ₹301.23
  • 200 Day
  • ₹285.82
  • 20 Day
  • ₹338.66
  • 50 Day
  • ₹318.36
  • 100 Day
  • ₹288.72
  • 200 Day
  • ₹274.80

Supriya Lifescience Resistance and Support

PIVOT
₹358.37
Resistance
First Resistance 364.73
Second Resistance 371.37
Third Resistance 377.73
RSI 60.93
MFI 69.81
MACD Single Line 13.46
MACD 13.57
Support
First Resistance 351.73
Second Resistance 345.37
Third Resistance 338.73

Supriya Lifescience Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 337,965 11,328,587 33.52
Week 364,667 15,057,117 41.29
1 Month 958,462 30,574,947 31.9
6 Month 577,656 21,956,712 38.01

Supriya Lifescience Result Highlights

Supriya Lifescience Synopsis

NSE-Medical-Supplies

Supriya Lifescience is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 460.94 Cr. and Equity Capital is Rs. 16.10 Cr. for the Year ended 31/03/2023. Supriya Lifescience Ltd. is a Public Limited Listed company incorporated on 26/03/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH2008PLC180452 and registration number is 180452.
Market Cap 2,876
Sales 554
Shares in Float 2.58
No of funds 20
Yield 0.17
Book Value 4.05
U/D Vol ratio 2
LTDebt / Equity
Alpha 0.17
Beta 0.74

Supriya Lifescience

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 68.3%68.3%68.3%68.28%
Mutual Funds 0.04%1.74%2.14%2.38%
Insurance Companies 3.81%3.89%3.86%3.73%
Foreign Portfolio Investors 4.56%5.35%5.73%5.66%
Individual Investors 17.51%16.1%15.4%15.55%
Others 5.78%4.62%4.57%4.4%

Supriya Lifescience Management

Name Designation
Mr. Satish Waman Wagh Chairman & Managing Director
Ms. Smita Satish Wagh Whole Time Director
Ms. Saloni Satish Wagh Whole Time Director
Ms. Shivani Satish Wagh Whole Time Director
Mr. Balasahab Gulabrao Sawant Whole Time Director
Mr. Kedar Shankar Karmarkar Independent Director
Mr. Bhairav Manojbhai Chokshi Independent Director
Mr. Dileep Kumar Jain Independent Director
Mr. Dinesh Navnitlal Modi Independent Director
Ms. Neelam Yashpal Arora Independent Director

Supriya Lifescience Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Supriya Lifescience Corporate Action

Date Purpose Remarks
2024-02-07 Quarterly Results
2023-11-07 Quarterly Results
2023-08-03 Quarterly Results
2023-05-26 Audited Results & Final Dividend
2023-02-14 Quarterly Results

Supriya Lifescience FAQs

What is Share Price of Supriya Lifescience ?

Supriya Lifescience share price is ₹358 As on 27 February, 2024 | 22:26

What is the Market Cap of Supriya Lifescience ?

The Market Cap of Supriya Lifescience is ₹2882.1 Cr As on 27 February, 2024 | 22:26

What is the P/E ratio of Supriya Lifescience ?

The P/E ratio of Supriya Lifescience is 23.9 As on 27 February, 2024 | 22:26

What is the PB ratio of Supriya Lifescience ?

The PB ratio of Supriya Lifescience is 4.1 As on 27 February, 2024 | 22:26

Q2FY23